Lantheus Holdings, parent company of Lantheus Medical Imaging, has released mixed results for its third quarter.
The company posted $88.5 million in worldwide revenue, a 3.2% increase over $85.8 million during the same period last year. It attributed this increase to sales of its Definity ultrasound contrast agent.
However, the firm also posted a net loss of $6.4 million for the quarter (end-September 30), compared with net income of $4.9 million in 2019.
In April, Lantheus Holdings withdrew its 2020 revenue, revenue growth, and earnings guidance due to the COVID-19 pandemic.
